Active Ingredient History
Elacestrant, sold under the brand name Orserdu, is an anticancer medication which is used in the treatment of breast cancer. It is taken by mouth. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Brain Diseases (Phase 1/Phase 2)
Brain Neoplasms (Phase 1/Phase 2)
Breast Diseases (Phase 1/Phase 2)
Breast Neoplasms (Phase 3)
Carcinoma, Intraductal, Noninfiltrating (Phase 2)
Central Nervous System Diseases (Phase 1/Phase 2)
Central Nervous System Neoplasms (Phase 1/Phase 2)
Hot Flashes (Phase 2)
Liver Diseases (Phase 1)
Neoplasms (Phase 2)
Neoplasms by Site (Phase 1/Phase 2)
Vasomotor System (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue